Interleukin-17 enhances immunosuppression by mesenchymal stem cells

Cell Death and Differentiation

Volumn 21, Issue 11, 2014, Pages 1758-1768

  Han, X ^a   Yang, Q ^a   Lin, L ^a   Xu, C ^a   Zheng, C ^a   Chen, X ^a   Han, Y ^a   Li, M ^b   Cao, W ^a   Cao, K ^a   Chen, Q ^a   Xu, G ^c   Zhang, Y ^c   Zhang, J ^c   Schneider, R J ^d   Qian, Y ^a   Wang, Y ^a   Brewer, G ^b   Shi, Y ^a,c  

^a SHANGHAI JIAO TONG UNIVERSITY SCHOOL OF MEDICINE   (China)

^b RUTGERS ROBERT WOOD JOHNSON MEDICAL SCHOOL   (United States)

^c CHILD HEALTH INSTITUTE OF NEW JERSEY   (United States)

^d NEW YORK UNIVERSITY SCHOOL OF MEDICINE   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

GAMMA INTERFERON; HETEROGENEOUS NUCLEAR RIBONUCLEOPROTEIN D; HNRNP D0; INDUCIBLE NITRIC OXIDE SYNTHASE; INTERLEUKIN 17; TUMOR NECROSIS FACTOR ALPHA;

ANIMAL; GENE EXPRESSION; IMMUNOLOGICAL TOLERANCE; IMMUNOLOGY; MESENCHYMAL STROMA CELL; METABOLISM; MOUSE; PHYSIOLOGY; RNA STABILITY;

ANIMALS; GENE EXPRESSION; HETEROGENEOUS-NUCLEAR RIBONUCLEOPROTEIN D; IMMUNE TOLERANCE; INTERFERON-GAMMA; INTERLEUKIN-17; MESENCHYMAL STROMAL CELLS; MICE; NITRIC OXIDE SYNTHASE TYPE II; RNA STABILITY; TUMOR NECROSIS FACTOR-ALPHA;

EID: 84932176456     PISSN: 13509047     EISSN: 14765403     Source Type: Journal    
DOI: 10.1038/cdd.2014.85     Document Type: Article

References (48)

1. Rouvier E, Luciani MF, Mattei MG, Denizot F, Golstein P. CTLA-8 cloned from an activated T cell, bearing AU-rich messenger RNA instability sequences, and homologous to a herpesvirus saimiri gene. J Immunol 1993; 150: 5445-5456.
2. Harrington LE, Hatton RD, Mangan PR, Turner H, Murphy TL, Murphy KM et al. Interleukin 17-producing CD4\+ effector T cells develop via a lineage distinct from the T helper type 1 and 2 lineages. Nat Immunol 2005; 6: 1123-1132.
3. Park H, Li Z, Yang XO, Chang SH, Nurieva R, Wang YH et al. A distinct lineage of CD4 T cells regulates tissue inflammation by producing interleukin 17. Nat Immunol 2005; 6: 1133-1141.
4. Kang Z, Altuntas CZ, Gulen MF, Liu C, Giltiay N, Qin H et al. Astrocyte-restricted ablation of interleukin-17-induced Act1-mediated signaling ameliorates autoimmune encephalomyelitis. Immunity 2010; 32: 414-425.
5. Chabaud M, Lubberts E, Joosten L, van Den Berg W, Miossec P. IL-17 derived from juxta-articular bone and synovium contributes to joint degradation in rheumatoid arthritis. Arthritis Res 2001; 3: 168-177.
6. Yang B, Wang Y, Zhao C, Yan W, Che H, Shen C et al. Increased Th17 cells and interleukin-17 contribute to immune activation and disease aggravation in patients with chronic hepatitis B virus infection. Immunol Lett 2013; 149: 41-49.
7. Yao Z, Fanslow WC, Seldin MF, Rousseau AM, Painter SL, Comeau MR et al. Herpesvirus Saimiri encodes a new cytokine, IL-17, which binds to a novel cytokine receptor. Immunity 1995; 3: 811-821.
8. Toy D, Kugler D, Wolfson M, Vanden Bos T, Gurgel J, Derry J et al. Cutting edge: interleukin 17 signals through a heteromeric receptor complex. J Immunol 2006; 177: 36-39.
9. Chang SH, Park H, Dong C. Act1 adaptor protein is an immediate and essential signaling component of interleukin-17 receptor. J Biol Chem 2006; 281: 35603-35607.
10. Qian Y, Liu C, Hartupee J, Altuntas CZ, Gulen MF, Jane-Wit D et al. The adaptor Act1 is required for interleukin 17-dependent signaling associated with autoimmune and inflammatory disease. Nat Immunol 2007; 8: 247-256.
11. Rosenbaum AJ, Grande DA, Dines JS. The use of mesenchymal stem cells in tissue engineering: a global assessment. Organogenesis 2008; 4: 23-27.
12. Xu G, Zhang L, Ren G, Yuan Z, Zhang Y, Zhao RC et al. Immunosuppressive properties of cloned bone marrow mesenchymal stem cells. Cell Res 2007; 17: 240-248.
13. Ren G, Zhang L, Zhao X, Xu G, Zhang Y, Roberts AI et al. Mesenchymal stem cell-mediated immunosuppression occurs via concerted action of chemokines and nitric oxide. Cell Stem Cell 2008; 2: 141-150.
14. Shi Y, Hu G, Su J, Li W, Chen Q, Shou P et al. Mesenchymal stem cells: a new strategy for immunosuppression and tissue repair. Cell Res 2010; 20: 510-518.
15. Shi Y, Su J, Roberts AI, Shou P, Rabson AB, Ren G. How mesenchymal stem cells interact with tissue immune responses. Trends Immunol 2012; 33: 136-143.
16. Wu X, Brewer G. The regulation of mRNA stability in mammalian cells: 2. 0. Gene 2012; 500: 10-21.
17. Garneau NL, Wilusz J, Wilusz CJ. The highways and byways of mRNA decay. Nat Rev Mol Cell Biol 2007; 8: 113-126.
18. Lu JY, Schneider RJ. Tissue distribution of AU-rich mRNA-binding proteins involved in regulation of mRNA decay. J Biol Chem 2004; 279: 12974-12979.
19. Gratacos FM, Brewer G. The role of AUF1 in regulated mRNA decay. Wiley Interdiscip Rev RNA 2011; 1: 457-473.
20. Pautz A, Linker K, Altenhofer S, Heil S, Schmidt N, Art J et al. Similar regulation of human inducible nitric-oxide synthase expression by different isoforms of the RNA-binding protein AUF1. J Biol Chem 2009; 284: 2755-2766.
21. Ali G, Mohsin S, Khan M, Nasir GA, Shams S, Khan SN et al. Nitric oxide augments mesenchymal stem cell ability to repair liver fibrosis. J Transl Med 2012; 10: 75.
22. Dalal J, Gandy K, Domen J. Role of mesenchymal stem cell therapy in Crohn's disease. Pediatr Res 2012; 71(4 Pt 2): 445-451.
23. Le Blanc K, Frassoni F, Ball L, Locatelli F, Roelofs H, Lewis I et al. Mesenchymal stem cells for treatment of steroid-resistant, severe, acute graft-versus-host disease: a phase II study. Lancet 2008; 371: 1579-1586.
24. Lee H, Park JB, Lee S, Baek S, Kim H, Kim SJ. Intra-osseous injection of donor mesenchymal stem cell (MSC) into the bone marrow in living donor kidney transplantation; a pilot study. J Transl Med 2013; 11: 96.
25. Ren G, Chen X, Dong F, Li W, Ren X, Zhang Y et al. Concise review: mesenchymal stem cells and translational medicine: emerging issues. Stem Cells Transl Med 2012; 1: 51-58.
26. Huang H, Kim HJ, Chang EJ, Lee ZH, Hwang SJ, Kim HM et al. IL-17 stimulates the proliferation and differentiation of human mesenchymal stem cells: implications for bone remodeling. Cell Death Differ 2009; 16: 1332-1343.
27. Xu G, Zhang Y, Zhang L, Roberts AI, Shi Y. C/EBPbeta mediates synergistic upregulation of gene expression by interferon-gamma and tumor necrosis factor-alpha in bone marrowderived mesenchymal stem cells. Stem Cells 2009; 27: 942-948.
28. Wang HX, Liu M, Weng SY, Li JJ, Xie C, He HL et al. Immune mechanisms of Concanavalin A model of autoimmune hepatitis. World J Gastroenterol 2012; 18: 119-125.
29. Hartupee J, Liu C, Novotny M, Li X, Hamilton T. IL-17 enhances chemokine gene expression through mRNA stabilization. J Immunol 2007; 179: 4135-4141.
30. Faour WH, Mancini A, He QW, Di Battista JA. T-cell-derived interleukin-17 regulates the level and stability of cyclooxygenase-2 (COX-2) mRNA through restricted activation of the p38 mitogen-activated protein kinase cascade: role of distal sequences in the 3'-untranslated region of COX-2 mRNA. J Biol Chem 2003; 278: 26897-26907.
31. Lu JY, Sadri N, Schneider RJ. Endotoxic shock in AUF1 knockout mice mediated by failure to degrade proinflammatory cytokine mRNAs. Genes Dev 2006; 20: 3174-3184.
32. Pappu R, Ramirez-Carrozzi V, Sambandam A. The interleukin-17 cytokine family: critical players in host defence and inflammatory diseases. Immunology 2011; 134: 8-16.
33. Li W, Ren G, Huang Y, Su J, Han Y, Li J et al. Mesenchymal stem cells: a double-edged sword in regulating immune responses. Cell Death Differ 2012; 19: 1505-1513.
34. van den Berg WB, Miossec P. IL-17 as a future therapeutic target for rheumatoid arthritis. Nat Rev Rheumatol 2009; 5: 549-553.
35. Ogawa A, Andoh A, Araki Y, Bamba T, Fujiyama Y. Neutralization of interleukin-17 aggravates dextran sulfate sodium-induced colitis in mice. Clin Immunol 2004; 110: 55-62.
36. O'Connor W Jr. , Kamanaka M, Booth CJ, Town T, Nakae S, Iwakura Y et al. A protective function for interleukin 17A in T cell-mediated intestinal inflammation. Nat Immunol 2009; 10: 603-609.
37. Ren G, Su J, Zhang L, Zhao X, Ling W, L'Huillie A et al. Species variation in the mechanisms of mesenchymal stem cell-mediated immunosuppression. Stem Cells 2009; 27: 1954-1962.
38. Lohse AW, Dienes HP, Meyer zum Buschenfelde KH. Suppression of murine experimental autoimmune hepatitis by T-cell vaccination or immunosuppression. Hepatology 1998; 27: 1536-1543.
39. Kubo N, Narumi S, Kijima H, Mizukami H, Yagihashi S, Hakamada K et al. Efficacy of adipose tissue-derived mesenchymal stem cells for fulminant hepatitis in mice induced by concanavalin A. J Gastroenterol Hepatol 2011; 27: 165-172.
40. Higashimoto M, Sakai Y, Takamura M, Usui S, Nasti A, Yoshida K et al. Adipose tissue derived stromal stem cell therapy in murine ConA-derived hepatitis is dependent on myeloid-lineage and CD4(\+) T-cell suppression. Eur J Immunol 2013; 43: 2956-2968.
41. Paschoud S, Dogar AM, Kuntz C, Grisoni-Neupert B, Richman L, Kuhn LC. Destabilization of interleukin-6 mRNA requires a putative RNA stem-loop structure, an AU-rich element, and the RNA-binding protein AUF1. Mol Cell Biol 2006; 26: 8228-8241.
42. Sirenko OI, Lofquist AK, DeMaria CT, Morris JS, Brewer G, Haskill JS. Adhesion-dependent regulation of an A\+U-rich element-binding activity associated with AUF1. Mol Cell Biol 1997; 17: 3898-3906.
43. Devadas S, Das J, Liu C, Zhang L, Roberts AI, Pan Z et al. Granzyme B is critical for T cell receptor-induced cell death of type 2 helper T cells. Immunity 2006; 25: 237-247.
44. Wang R, Shi YF. A simplified protocol for apoptosis assay by DNA content analysis. Biotechniques 2002; (Suppl): 88-91.
45. Ysla RM, Wilson GM, Brewer G. Chapter 3Assays of adenylate uridylate-rich elementmediated mRNA decay in cells. Methods Enzymol 2008; 449: 47-71.
46. Livak KJ, Schmittgen TD. Analysis of relative gene expression data using real-time quantitative PCR and the 2(-Delta Delta C(T)) Method. Methods 2001; 25: 402-408.
47. Schmittgen TD, Zakrajsek BA, Mills AG, Gorn V, Singer MJ, Reed MW. Quantitative reverse transcription-polymerase chain reaction to study mRNA decay: comparison of endpoint and real-time methods. Anal Biochem 2000; 285: 194-204.
48. Lee WY, Salmi M, Kelly MM, Jalkanen S, Kubes P. Therapeutic advantage of anti-VAP-1 over anti-alpha4 integrin antibody in concanavalin a-induced hepatitis. Hepatology 2013; 58: 1413-1423.